Stock Events

Stock Events

Airsculpt Technologies 

$2.67
26
-$0.14-4.98% Thursday 20:00
+$0.00+0%Thursday 23:30After hours

Statistics

Day High
2.69
Day Low
2.67
52W High
12
52W Low
1.51
Volume
20,312
Avg. Volume
-
Mkt Cap
192.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 22
$0.41
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.08
-0.05
-0.01
0.02
Expected EPS
-0.03
Actual EPS
N/A

Financials

-7.68%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
151.82MRevenue
-11.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIRS. It's not an investment recommendation.
Amazon
2
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
DENTSPLY Sirona
XRAY
Mkt Cap2.31B
Dentsply Sirona, while primarily focused on dental products, has ventured into the aesthetic space with technologies that could be seen as complementary or competitive to Airsculpt's offerings.
Stryker
SYK
Mkt Cap130.11B
Stryker Corporation, known for medical devices and equipment, has made inroads into the aesthetics market through acquisitions, potentially competing with Airsculpt's surgical solutions.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson's Ethicon offers products for plastic surgery, and its broad healthcare and aesthetic solutions can compete with Airsculpt's procedures.
Medtronic
MDT
Mkt Cap116.83B
Medtronic, with its medical devices and technologies, has capabilities that could extend into aesthetic and cosmetic surgery, posing competition to Airsculpt.
Intuitive Surgical
ISRG
Mkt Cap139.37B
Intuitive Surgical's robotic-assisted surgical systems, while not directly aesthetic, represent advanced surgical technologies that could compete with Airsculpt's minimally invasive approaches.
Pfizer
PFE
Mkt Cap152.69B
Pfizer, through its consumer healthcare and potential future aesthetic products, could enter markets that compete with Airsculpt's cosmetic procedures.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie, after acquiring Allergan, has a strong presence in the aesthetics market with products like Botox and Juvederm, competing in the same space as Airsculpt.

About

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
Show more...
CEO
Yogi Jashnani
Employees
363
Country
United States
ISIN
US0094961002

Listings

XNAS
US
AIRS
BOATS
BOATS
AIRS.BOATS

0 Comments

Share your thoughts

FAQ

What is Airsculpt Technologies stock price today?▼
The current price of AIRS is $2.67 USD — it has decreased by -4.98% in the past 24 hours. Watch Airsculpt Technologies stock price performance more closely on the chart.
What is Airsculpt Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Airsculpt Technologies stocks are traded under the ticker AIRS.
Is Airsculpt Technologies stock price growing?▼
AIRS stock has fallen by -22.16% compared to the previous week, the month change is a -45.06% fall, over the last year Airsculpt Technologies has showed a -54.67% decrease.
What is Airsculpt Technologies market cap?▼
Today Airsculpt Technologies has the market capitalization of 192.49M
When is the next Airsculpt Technologies earnings date?▼
Airsculpt Technologies is going to release the next earnings report on November 05, 2026.
What were Airsculpt Technologies earnings last quarter?▼
AIRS earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0.02 USD resulting in a -33.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Airsculpt Technologies revenue for the last year?▼
Airsculpt Technologies revenue for the last year amounts to 151.82M USD.
What is Airsculpt Technologies net income for the last year?▼
AIRS net income for the last year is -11.67M USD.
Does Airsculpt Technologies pay dividends?▼
Yes, AIRS dividends are paid en. The last dividend per share was 0.41 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Airsculpt Technologies have?▼
As of August 21, 2026, the company has 363 employees.
In which sector is Airsculpt Technologies located?▼
Airsculpt Technologies operates in the Health & Wellness sector.
When did Airsculpt Technologies complete a stock split?▼
Airsculpt Technologies has not had any recent stock splits.
Where is Airsculpt Technologies headquartered?▼
Airsculpt Technologies is headquartered in MIAMI BEACH, United States.